Literature DB >> 18679370

Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens.

X Cahu, M Mohty, C Faucher, P Chevalier, N Vey, J El-Cheikh, T Guillaume, S Furst, J Delaunay, S Ayari, P Moreau, J A Gastaut, J L Harousseau, D Blaise.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18679370     DOI： 10.1038/bmt.2008.231

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  2 in total

1.  Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning.

Authors:  Mehdi Hamadani; Michael Craig; Gary S Phillips; Jame Abraham; William Tse; Aaron Cumpston; Laura Gibson; Scot C Remick; Pamela Bunner; Sonia Leadmon; Patrick Elder; Craig Hofmeister; Sam Penza; Yvonne Efebera; Leslie Andritsos; Ramiro Garzon; Don M Benson; William Blum; Steven M Devine
Journal:  Hematol Oncol       Date:  2011-02-28       Impact factor: 5.271

2.  Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized study.

Authors:  Simrit Parmar; Gabriela Rondon; Marcos de Lima; Peter Thall; Ronald Bassett; Paolo Anderlini; Partow Kebriaei; Issa Khouri; Prasanth Ganesan; Richard Champlin; Sergio Giralt
Journal:  Biol Blood Marrow Transplant       Date:  2012-12-07       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.